CAR-T cell therapy remains viable for patients in lymphoma remission, study finds
For some patients who receive cell therapy such as CAR-T cells, this comes after many other treatments have failed. Researchers noticed that their patients who received the cells while in remission tended to do well after their infusion. They proposed a research study to follow patients who had received a transplant and/or cell therapy. The […]